Generational Equity Advises Catachem in its Sale to Private Investor

By Generational Group


Generational Equity, a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the sale of its client, Catachem, Inc., to a Private Investor. The deal closed February 28, 2023.

Catachem, Inc., located in Oxford, Connecticut, is a leading U.S.-based manufacturer of clinical chemistry reagents for use on automated analyzers for both veterinary and human diagnostic labs. The Company’s reagents offer strong performance in terms of accuracy, precision, stability and cost.

Generational Equity Executive Managing Director, M&A-Technology Practice Leader, David Fergusson, and his team, led by Senior M&A Advisor, Ray Palombi, with the support of Managing Director, M&A, Corey Painter, successfully closed the transaction. Executive Managing Director Bill Kushnir established the initial relationship with Catachem.

‘’Catachem is an innovative company with a long history as an industry leader. We were able to find the right buyer, with an experienced management team, to carry the company forward,” said Palombi.

About Generational

Headquartered in Dallas, Generational is one of the leading M&A advisory firms in North America.

With more than 350 professionals located throughout 17 offices in North America, the companies help business owners release the wealth of their business by providing growth consulting, merger, acquisition, and wealth management services. Their six-step approach features strategic and tactical growth consulting, exit planning education, business valuation, value enhancement strategies, M&A transactional services, and wealth management.

The M&A Advisor named the company Investment Banking Firm of the Year three years in a row, Valuation Firm of the Year in 2020, and North American Investment Bank of the Year in 2022 as well as Consulting Firm of the Year. For more information, visit